Patent US1496725A successfully refreshed from Google Patents.
Patent US5468619A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5468619A Expired / Lapsed US ⏱️ 0.0 years remaining

Screening method for identifying women at increased risk for imminent delivery

Assignee: Cytyc Corp
•
Filing: 1993-05-12
•
Granted: 1995-11-21
•
Expires: 2013-05-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention provides an early, biochemical indication of increased risk of impending delivery. The method is particularly useful to identify those pregnant women who are at increased risk for preterm delivery and can also be used to identify those women at risk for a post-date delivery. The method comprises obtaining a cervicovaginal secretion sample from a pregnant patient after week 12 of gestation and determining the level of total fibronectin in the sample. The presence of an elevated fibronectin level in the sample indicates an increased risk of delivery. The test detects greater than 80% of women who deliver prematurely, as early as two to three weeks prior to delivery.

Inventors

  • 👤 Andrew E. Senyei
  • 👤 David C. Casal

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 23:45
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/68; G01N33/689; G01N2800/00; G01N2800/36; G01N2800/368; Y; Y10; Y10S; Y10S436/00; Y10S436/811; Y10S436/814

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 63 words
An immunoassay method of screening for an increased risk of impending delivery comprising: a) obtaining a secretion sample from the vaginal cavity or the cervical canal from a pregnant patient after week 12 of pregnancy; and b) determining the level of total fibronectin in the sample, wherein an elevated level of total fibronectin in the sample suggests an increased risk of impending delivery.
Claim 2
Dependent Claim 63 words
An immunoassay method of screening for an increased risk of impending delivery comprising: a) obtaining a secretion sample from the vaginal cavity or the cervical canal from a pregnant patient after week 12 of pregnancy; and b) determining the level of total fibronectin in the sample, wherein an elevated level of total fibronectin in the sample suggests an increased risk of impending delivery.
Claim 3
Dependent Claim 14 words
The method of claim 1 wherein the sample is obtained from the posterior fornix.
Claim 4
Dependent Claim 14 words
The method of claim 1 wherein the sample is obtained from the cervical os.
Claim 5
Dependent Claim 61 words
The method of claim 1 wherein the sample obtained from the patient is determined not to have an elevated total fibronectin level and the method further comprises repeating the steps of the method with at least one other sample from the patient obtained at least two weeks after the sample determined not to have an elevated total fibronectin level was obtained.
Claim 6
Dependent Claim 55 words
The method of claim 4 wherein said other sample is obtained 2 weeks to about 4 weeks after obtaining the sample and the steps of the method are repeated with a succession of one or more other samples until the patient delivers or a sample determined to have an elevated total fibronectin level is obtained.
Claim 7
Dependent Claim 62 words
The method of claim 1 wherein the sample is determined to have an elevated total fibronectin level and the method further comprises performing a second immunoassay to determine the presence of fetal fibronectin in a sample of cervicovaginal secretions obtained from the patient wherein determination of the presence of fetal fibronectin by said second immunoassay confirms the increased risk of impending delivery.
Claim 8
Dependent Claim 57 words
The method of claim 6 wherein the sample of cervicovaginal secretions is determined not to contain fetal fibronectin and the method further comprises repeating the determination of fetal fibronectin with at least one other sample of cervicovaginal secretions from the patient obtained at least one week after the sample determined not to contain fetal fibronectin was obtained.
Claim 9
Dependent Claim 55 words
The method of claim 7 wherein said other sample of cervicovaginal secretions is obtained 2 weeks after obtaining the sample and the determination of fetal fibronectin is repeated with a succession of one or more other samples obtained at two week intervals until the patient delivers or a sample positive for fetal fibronectin is obtained.
Claim 10
Dependent Claim 47 words
The method of claim 1 wherein the determining step comprises the steps of: a) contacting the sample with a first anti-(total fibronectin) antibody for a time sufficient for antigen-antibody binding; and b) determining the amount of binding to determine the level of total fibronectin in the sample.
Claim 11
Dependent Claim 79 words
The method of claim 9 wherein said first anti-(total fibronectin) antibody is affixed to a solid phase and the amount of binding is determined by: a) contacting the sample with a second anti-(total fibronectin) antibody for a time sufficient for antigen-antibody binding, said second anti-(total fibronectin) antibody being directly or indirectly labeled; and b) determining the amount of label on said second antibody specifically bound to the solid phase to determine the level of total fibronectin in the sample.
Claim 12
Dependent Claim 16 words
The method of claim 10 wherein the labeled anti-(total fibronectin) antibody is conjugated to a label.
Claim 13
Dependent Claim 11 words
The method of claim 11 wherein the label is an enzyme.
Claim 14
Dependent Claim 30 words
The method of claim 10 wherein the labeled anti-(total fibronectin) antibody is indirectly labeled by reacting the anti-(total fibronectin) antibody with a labeled antibody specific for the anti-(total fibronectin) antibody.

References Cited (Backward Citations)

EP0316919A2 Cited
US5096830A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1998-11-20 1999-05-22 1999-11-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2002-11-20 2003-05-22 2003-11-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2006-11-20 2007-05-22 2007-11-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag